Article Details

Sarepta looks for quick approval for Duchenne muscular dystrophy gene therapy treatment

Retrieved on: 2022-07-29 14:15:46

Tags for this article:

Click the tags to see associated articles and topics

Sarepta looks for quick approval for Duchenne muscular dystrophy gene therapy treatment. View article details on hiswai:

Excerpt

In December 2019, Roche partnered with Sarepta to combine Roche's global reach, commercial presence and regulatory expertise with Sarepta's gene ...

Article found on: www.labiotech.eu

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up